RNASeq profiling of COVID19-infected patients identified an EIF2AK2 inhibitor as a potent SARS-CoV-2 antiviral.

ABSTRACT:

SUBMITTER: Jain S 

PROVIDER: S-EPMC9627224 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature